77 related articles for article (PubMed ID: 9366985)
1. Bone marrow transplantation.
Ruutu T
Ann Chir Gynaecol; 1997; 86(2):127-37. PubMed ID: 9366985
[No Abstract] [Full Text] [Related]
2. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course.
Kochethu G; Baden HS; Jaworska E; Chang J; Chopra R
Bone Marrow Transplant; 2005 Jul; 36(1):81-2. PubMed ID: 15895117
[No Abstract] [Full Text] [Related]
3. Rapid-onset leucodrema associated with graft-versus-host disease.
Jacobsohn DA; Ruble K; Moresi JM; Vogelsang GB
Bone Marrow Transplant; 2002 Nov; 30(10):705-6. PubMed ID: 12420211
[No Abstract] [Full Text] [Related]
4. Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation.
Mori T; Yamada Y; Aisa Y; Uemura T; Ishida A; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2005 Aug; 36(3):263-4. PubMed ID: 15937504
[No Abstract] [Full Text] [Related]
5. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
Bacigalupo A
Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
[No Abstract] [Full Text] [Related]
7. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH
Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
[TBL] [Abstract][Full Text] [Related]
8. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
[No Abstract] [Full Text] [Related]
9. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ
Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Araten DJ; Luzzatto L
Haematologica; 2000 Jan; 85(1):1-2. PubMed ID: 10627666
[No Abstract] [Full Text] [Related]
11. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
[TBL] [Abstract][Full Text] [Related]
12. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
13. Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant?
Shaw PJ; Bleakley M; Lau L
Bone Marrow Transplant; 2004 Aug; 34(3):275-6. PubMed ID: 15156168
[No Abstract] [Full Text] [Related]
14. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in allogeneic hematopoietic stem-cell transplantation.
Devine SM; Adkins DR; Khoury H; Brown RA; Vij R; Blum W; DiPersio JF
J Lab Clin Med; 2003 Jan; 141(1):7-32. PubMed ID: 12518165
[No Abstract] [Full Text] [Related]
16. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the tongue after bone marrow transplant and graft-versus-host disease: a case report and review of the literature.
Byun JH; Park BW; Kim JR; Lee GW; Lee JH
J Oral Maxillofac Surg; 2008 Jan; 66(1):144-7. PubMed ID: 18083430
[No Abstract] [Full Text] [Related]
18. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
[TBL] [Abstract][Full Text] [Related]
19. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
Chan GW; Gorgun G; Miller KB; Foss FM
Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
[TBL] [Abstract][Full Text] [Related]
20. Unrelated bone marrow transplantation for leukocyte adhesion deficiency.
Farinha NJ; Duval M; Wagner E; Champagne J; Lapointe N; Barrette S; Tapiero B; Busque L; Champagne MA
Bone Marrow Transplant; 2002 Dec; 30(12):979-81. PubMed ID: 12476295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
